140 related articles for article (PubMed ID: 1832158)
21. Analysis of recognition in the alternative pathway of complement. Effect of polysaccharide size.
Pangburn MK
J Immunol; 1989 Apr; 142(8):2766-70. PubMed ID: 2467939
[TBL] [Abstract][Full Text] [Related]
22. Identification of a heparin binding domain in the seventh short consensus repeat of complement factor H.
Blackmore TK; Sadlon TA; Ward HM; Lublin DM; Gordon DL
J Immunol; 1996 Dec; 157(12):5422-7. PubMed ID: 8955190
[TBL] [Abstract][Full Text] [Related]
23. Human complement factor H: isolation of cDNA clones and partial cDNA sequence of the 38-kDa tryptic fragment containing the binding site for C3b.
Schulz TF; Schwäble W; Stanley KK; Weiss E; Dierich MP
Eur J Immunol; 1986 Nov; 16(11):1351-5. PubMed ID: 2946589
[TBL] [Abstract][Full Text] [Related]
24. Role of human factor I and C3b receptor in the cleavage of surface-bound C3bi molecules.
Medicus RG; Melamed J; Arnaout MA
Eur J Immunol; 1983 Jun; 13(6):465-70. PubMed ID: 6222909
[TBL] [Abstract][Full Text] [Related]
25. Structural characterization of factor I mediated cleavage of the third component of complement.
Davis AE; Harrison RA
Biochemistry; 1982 Nov; 21(23):5745-9. PubMed ID: 6217832
[No Abstract] [Full Text] [Related]
26. Mapping of the sites responsible for factor I-cofactor activity for cleavage of C3b and C4b on human C4b-binding protein (C4bp) by deletion mutagenesis.
Fukui A; Yuasa-Nakagawa T; Murakami Y; Funami K; Kishi N; Matsuda T; Fujita T; Seya T; Nagasawa S
J Biochem; 2002 Nov; 132(5):719-28. PubMed ID: 12417021
[TBL] [Abstract][Full Text] [Related]
27. Pinpointing the putative heparin/sialic acid-binding residues in the 'sushi' domain 7 of factor H: a molecular modeling study.
Ranganathan S; Male DA; Ormsby RJ; Giannakis E; Gordon DL
Pac Symp Biocomput; 2000; ():155-67. PubMed ID: 10902165
[TBL] [Abstract][Full Text] [Related]
28. Mapping the Complement Factor H-Related Protein 1 (CFHR1):C3b/C3d Interactions.
Hannan JP; Laskowski J; Thurman JM; Hageman GS; Holers VM
PLoS One; 2016; 11(11):e0166200. PubMed ID: 27814381
[TBL] [Abstract][Full Text] [Related]
29. Staphylococcal Ecb protein and host complement regulator factor H enhance functions of each other in bacterial immune evasion.
Amdahl H; Jongerius I; Meri T; Pasanen T; Hyvärinen S; Haapasalo K; van Strijp JA; Rooijakkers SH; Jokiranta TS
J Immunol; 2013 Aug; 191(4):1775-84. PubMed ID: 23863906
[TBL] [Abstract][Full Text] [Related]
30. Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis.
Klickstein LB; Bartow TJ; Miletic V; Rabson LD; Smith JA; Fearon DT
J Exp Med; 1988 Nov; 168(5):1699-717. PubMed ID: 2972794
[TBL] [Abstract][Full Text] [Related]
31. Identification of cell-surface heparin/heparan sulfate-binding proteins of a human uterine epithelial cell line (RL95).
Raboudi N; Julian J; Rohde LH; Carson DD
J Biol Chem; 1992 Jun; 267(17):11930-9. PubMed ID: 1601862
[TBL] [Abstract][Full Text] [Related]
32. Phagocytosis by human monocytes of particles activating the alternative pathway of complement.
Johnson E; Eskeland T; Bertheussen K
Scand J Immunol; 1984 Jan; 19(1):31-9. PubMed ID: 6701471
[TBL] [Abstract][Full Text] [Related]
33. Functional properties of complement factor H-related proteins FHR-3 and FHR-4: binding to the C3d region of C3b and differential regulation by heparin.
Hellwage J; Jokiranta TS; Koistinen V; Vaarala O; Meri S; Zipfel PF
FEBS Lett; 1999 Dec; 462(3):345-52. PubMed ID: 10622723
[TBL] [Abstract][Full Text] [Related]
34. Effect of trypsinization on the activity of human factor H.
Hong K; Kinoshita T; Dohi Y; Inoue K
J Immunol; 1982 Aug; 129(2):647-52. PubMed ID: 6211491
[No Abstract] [Full Text] [Related]
35. Structure of vaccinia complement protein in complex with heparin and potential implications for complement regulation.
Ganesh VK; Smith SA; Kotwal GJ; Murthy KH
Proc Natl Acad Sci U S A; 2004 Jun; 101(24):8924-9. PubMed ID: 15178763
[TBL] [Abstract][Full Text] [Related]
36. Kinetic analysis of glycoprotein C of herpes simplex virus types 1 and 2 binding to heparin, heparan sulfate, and complement component C3b.
Rux AH; Lou H; Lambris JD; Friedman HM; Eisenberg RJ; Cohen GH
Virology; 2002 Mar; 294(2):324-32. PubMed ID: 12009874
[TBL] [Abstract][Full Text] [Related]
37. Molecular modelling of the C-terminal domains of factor H of human complement: a correlation between haemolytic uraemic syndrome and a predicted heparin binding site.
Perkins SJ; Goodship TH
J Mol Biol; 2002 Feb; 316(2):217-24. PubMed ID: 11851332
[TBL] [Abstract][Full Text] [Related]
38. Disturbed sialic acid recognition on endothelial cells and platelets in complement attack causes atypical hemolytic uremic syndrome.
Hyvärinen S; Meri S; Jokiranta TS
Blood; 2016 Jun; 127(22):2701-10. PubMed ID: 27006390
[TBL] [Abstract][Full Text] [Related]
39. Demonstration of factor H-like protein 1 binding to Treponema denticola, a pathogen associated with periodontal disease in humans.
McDowell JV; Lankford J; Stamm L; Sadlon T; Gordon DL; Marconi RT
Infect Immun; 2005 Nov; 73(11):7126-32. PubMed ID: 16239506
[TBL] [Abstract][Full Text] [Related]
40. The yeast Candida albicans binds complement regulators factor H and FHL-1.
Meri T; Hartmann A; Lenk D; Eck R; Würzner R; Hellwage J; Meri S; Zipfel PF
Infect Immun; 2002 Sep; 70(9):5185-92. PubMed ID: 12183569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]